Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Isoxazolines as therapeutic agents

Isoxazolines as therapeutic agents

US Patent 9029409 · Granted May 12, 2015

Estimated economic value: $109,016,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Matriptase 2 inhibitors and uses thereof2025
Pyridazine derivatives as SMARCA2/4 degraders2025
Substituted heterocyclyl derivatives as CDK inhibitors2025
Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate ox2025
Pyrazolo[1,5-A][1,3,5]triazine and pyrazolo[1,5-A]pyrimidine derivatives as CDK 2021
Substituted heterocyclyl derivatives as CDK inhibitors2021
Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate ox2021
1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotat2021
1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotat2021
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/2021
Substituted pyrazole derivatives as selective CDK12/13 inhibitors2021
Substituted heterocyclyl derivatives as CDK inhibitors2020